Covid-19 Coronavirus Bemari

Ii bemari ek virus ke kaaran hoe hae jo saans lene ke system ko kharaab kare hae ii severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) naam se janii jaati hae. ii bemari ka pahilaa case December 2019me Wuhan, China me milaa rahaa.

Coronavirus disease 2019 (COVID-19)
Other names	COVID, (the) coronavirus
Transmission and life-cycle of SARS-CoV-2, which causes COVID-19
Specialty	Infectious disease
Symptoms	Fever, cough, fatigue, shortness of breath, vomiting, loss of taste or smell; some cases asymptomatic
Complications	Pneumonia, sepsis, ARDS, kidney failure, respiratory failure, pulmonary fibrosis, CKS, MIS-C, long COVID
Usual onset	2–14 days (typically 5) after infection
Duration	5 days to chronic
Causes	SARS-CoV-2
Diagnostic method	RT PCR testing, CT scan, rapid antigen test
Prevention	Vaccination, face coverings, quarantine, social distancing, ventilation, hand washing
Treatment	Symptomatic and supportive
Frequency	676,609,955 cases
Deaths	6,881,955

• COVID-19 mahamari ( Pandemic)

Health agencies

• Coronavirus (COVID‑19) by the UK National Health Service (NHS)
• Coronavirus 2019 (COVID-19) by the US Centers for Disease Control and Prevention (CDC)
• Coronavirus disease (COVID‑19) Facts by the World Health Organization (WHO)

Medical journals

• BMJ's Coronavirus (covid‑19) Hub by the BMJ
• Coronavirus (Covid‑19) by The New England Journal of Medicine
• Coronavirus (COVID‑19) Research Highlights by Springer Nature
• Coronavirus Disease 2019 (COVID‑19) by JAMA
• COVID‑19 Resource Centre by The Lancet
• Covid‑19: Novel Coronavirus

Treatment guidelines

• "Bouncing Back From COVID-19: Your Guide to Restoring Movement" (PDF). Johns Hopkins Medicine.
• "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines" (PDF). National Institutes of Health.
• "Guidelines on the Treatment and Management of Patients with COVID-19". Infectious Diseases Society of America.
• "JHMI Clinical Recommendations for Available Pharmacologic Therapies for COVID-19" (PDF). Johns Hopkins Medicine.
• NHS England and NHS Improvement. National Guidance for post-COVID syndrome assessment clinics (Report).
• World Health Organization (2022). Therapeutics and COVID-19: living guideline, 14 January 2022 (Report). hdl:10665/351006. WHO/2019-nCoV/therapeutics/2022.1.